← Back to Search

Nasal Spray for Coronavirus

Phase 3
Waitlist Available
Led By Gustavo Ferrer, MD
Research Sponsored by Larkin Community Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 7 days
Awards & highlights

Study Summary

This study is evaluating whether a nasal spray may help treat colds.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline reactive to non-reactive on COVID 19 RT PCR in 7 days
Secondary outcome measures
Change of time to clinical recovery from baseline within 7 days

Side effects data

From 2008 Phase 2 trial • 24 Patients • NCT00620854
50%
Nausea
25%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
rsCTA Then Fortical Then rsCTB
rsCTB Then rsCTA Then Fortical
Fortical Then rsCTA Then rsCTB
Fortical Then rsCTB Then rsCTA
rsCTA Then rsCTB Then Fortical
rsCTB Then Fortical Then rsCTA

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: TreatmentExperimental Treatment1 Intervention
Xylitol plus Grapefruit Seed Extract (Xlear) nasal spray, 2 puffs per nosetrils, every 6 hours
Group II: No treatmentActive Control1 Intervention
No treatment given
Group III: PlaceboPlacebo Group1 Intervention
Saline nasal spray, 2 puffs per nosetrils, every 6 hours
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nasal Spray
2008
Completed Phase 2
~120

Find a Location

Who is running the clinical trial?

Ferrer Medical InnovationsUNKNOWN
Xlear, IncIndustry Sponsor
1 Previous Clinical Trials
80 Total Patients Enrolled
XlearUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Michigan
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2
Gustavo Ferrer, M.D. 2021. "Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04610801.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top